Bearish
5
Neutral
4
Bullish
5
Bearish
35
Neutral
5
Bullish
6
Bearish
30
Neutral
1
Bullish
1
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Pharmaceuticals
Pharmaceuticals - Indian - Formulations
1,412 Cr
High Risk
22.4
43.8
0.6
3.7
23.46
14.10
Sales CAGR
1Y
76.55%
3Y
28.20%
5Y
17.63%
10Y
10.69%
Profit CAGR
1Y
95.30%
3Y
35.17%
5Y
27.95%
10Y
18.82%
ROE
TTM
16.66%
3Y
10.49%
5Y
10.95%
10Y
10.26%
ROCE
TTM
22.00%
3Y
14.40%
5Y
14.99%
10Y
13.81%
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
LOW RISK

Market Cap
₹ 1,412 Cr
P/E
22.42
Turned 1 L into 4.05 L in last 5 Years